• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Daiichi Sankyo to Cut 1200 US Jobs


October 19, 2015.

Daiichi Sankyo will "reorganize its U.S. Commercial organization as it transfers to a differentiated specialty portfolio that will include areas such as cardiovascular, pain management and oncology", the company has announced. 

The company says it "will reduce expenses, including a reduction in headcount, from its U.S. Commercial operations". It expects to eliminate 1,000 to 1,200 positions across the country, from the Commercial Home Office, located in Parsippany, NJ, and field-based sales and other positions throughout the country. The company added that the reorganization is not focused on the U.S.-based R&D function concentrated in Edison, NJ, or the packaging plant in Bethlehem, PA.


Related Videos